3-Substituted-4-oxa-1-azabicyclo [3,2,0]heptan-7-one as cysteine protease inhibitors

摘要

The use of certain 3-substituted-4-oxa-1-azabicyclo[3,2,0] heptan-7-one derivatives of general formula I, or physiologically acceptable salts thereof or isomers thereof, as active ingredients for the preparation of pharmaceutical composition and treatment of different diseases associated with deregulation of cysteine proteases is disclosed.